‘Pharmaceutical corporations, like Novo Nordisk, have been using underdeveloped countries as testing grounds for experimental drug trials. Doctors are beginning to speak out against this practice, citing that it has more to do with increasing profits and less to do with scientific research.

In countries like India and South Africa, where the citizens pay for their medicines, these drug trials are quite profitable for drug corporations.

While drug licensing authorities do not require post-marketing studies, major drug corporations regularly contend that they must conduct more experiments on the human population. Using third-world nations is the easiest way to do so considering that the general population in those countries does not have the ability to speak out and protest.’